Shows promise for women with other drugs triple-negative breast cancer

In the nationwide survey of women with triple-negative breast cancer angiogenesis inhibitors led to rapid increase in number of carboplatin chemotherapy using drugs or with a standard chemotherapy drug Avastin off completely, the tumor shrank, adding investigators, reported at the San Antonio Breast Cancer Symposium 2013. In the study, cancer and leukemia Group B hosted by new Faber Cancer Institute, Brown University, University of Texas MD Anderson Cancer Center, UNC Lineberger comprehensive cancer include author from the Center. New York University, Washington University in St. Louis, hope comprehensive cancer center and Mount Sinai Medical Center.

View the original article here